Related Experiment Video
Updated: Jul 28, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Non-secretory Multiple Myeloma: A Report of a Rare Case
Jacob T Harris1, Alexa Viniotis1, John Bibb2
1Internal Medicine, HonorHealth, Scottsdale, USA.
Abstract:
Multiple myeloma (MM) is a rare blood cancer. Non-measurable MM (NMMM) is a category designation consisting of both non-secretory MM (NSMM) and oligo-secretory MM (OSMM), both of which have negative findings on serum protein electrophoresis and urine protein electrophoresis testing. NSMM and OSMM are infrequent subtypes. This report describes the case of a 67-year-old female patient without significant past medical history who presented with back pain, nausea, fatigue, and mild confusion. Labs were significant for severe hypercalcemia. Imaging demonstrated osteopenia and multiple lytic lesions throughout her spine. Serum protein electrophoresis and immunofixation by electrophoresis were obtained but were inconclusive. Bone marrow biopsy was therefore obtained to help clarify the diagnosis. Workup ultimately revealed a new diagnosis of kappa light chain-restricted NSMM. It is beneficial for the clinician to review the classic features of general MM in such a case, and they are also worth reviewing, as it may be better characterized as OSMM. Recognizing the rare features of NSMM and OSMM is relevant since these are entities not commonly encountered and can appear as classic MM in the initial workup. The care of patients will continue to improve as the medical community continues to recognize the rare malignancy of MM and its variant forms of NMMM, specifically NSMM and OSMM.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018